Curcumin 用于 克罗恩病
C 证据 来自小型研究的证据有限，但存在一些积极信号。Limited RCT evidence. Some improvement in CDAI scores but results inconsistent. Better evidence exists for UC than Crohn's.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'gutcited.com';
const params = 'ingredient\u003Dcurcumin\u0026condition\u003Dibd\u002Dcrohns\u002Ddisease';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
C
结论
Limited RCT evidence. Some improvement in CDAI scores but results inconsistent. Better evidence exists for UC than Crohn's.
Key Study Findings
Meta-Analysis
n=2260
Comparative Efficacy of Medical Therapies in Reducing the Risk of Postoperative Recurrence in Crohn's Disease: …
Dose: None
vs: placebo or other medical therapies
Outcome: endoscopic recurrence (Rutgeerts score >= i2) at 6 …
效果: adalimumab vs thiopurines OR 0.33 (95% CI 0.12-0.91); adalimumab vs vitamin D OR 0.07 (95% CI 0.01-0
None
研究人群: patients with Crohn's disease post-surgery from 42 studies (38 RCTs)
Meta-Analysis
Curcumin for the clinical treatment of inflammatory bowel diseases: a systematic review and meta-analysis of …
Dose: Varying dosages
vs: Placebo
Outcome: Clinical remission and response in UC
效果: None
None
研究人群: UC and CD patients (13 RCTs)
Systematic Review
[Phytotherapeutic recommendations in medical guidelines for the treatment of gastroenterological diseases - a systematic review].
Dose: Peppermint oil, STW-5, psyllium, others
vs: Standard care or placebo
Outcome: Symptom improvement in GI diseases
效果: None
None
研究人群: Patients with gastroenterological diseases
Review
Use of curcumin and its nanopreparations in the treatment of inflammatory bowel disease.
Dose: Curcumin nanoformulations
vs: None
Outcome: IBD symptom improvement
效果: None
None
研究人群: IBD patients (preclinical/clinical review)
Review
Phytochemicals and Regulation of NF-kB in Inflammatory Bowel Diseases: An Overview of In Vitro and …
Dose: Various phytochemicals
vs: None
Outcome: NF-kB regulation in IBD
效果: None
None
研究人群: In vitro and in vivo IBD models
Meta-Analysis
Curcumin and Curcuma longa Extract in the Treatment of 10 Types of Autoimmune Diseases: A …
Dose: None
vs: Placebo or standard care
Outcome: Clinical/laboratory outcomes in autoimmune diseases
效果: None
None
研究人群: Patients with 10 types of autoimmune diseases
Key Statistics
3
研究数量
200
受试者
↔
Mixed
C
等级
Referenced Papers
Inflammatory bowel diseases
2026
Curcumin for the clinical treatment of inflammatory bowel diseases: a systematic review and meta-analysis of placebo-controlled randomized clinical trials.
Systematic Review
Frontiers in nutrition
2025
8 次引用
[Phytotherapeutic recommendations in medical guidelines for the treatment of gastroenterological diseases - a systematic review].
Systematic Review
Zeitschrift fur Gastroenterologie
2024
3 次引用
World journal of …
2024
Metabolites
2023
134 次引用
Frontiers in immunology
2022
68 次引用
Molecules (Basel, Switzerland)
2021
85 次引用
Effects of the Use of Curcumin on Ulcerative Colitis and Crohn's Disease: A Systematic Review.
Meta-Analysis
Journal of medicinal …
2021
52 次引用
United European gastroenterology …
2021
41 次引用
European journal of …
2021
40 次引用
A Systematic Review of the Clinical Use of Curcumin for the Management of Gastrointestinal Diseases.
Systematic Review
Advances in experimental …
2021
8 次引用
Journal of Crohn's …
2020
71 次引用
Clinical gastroenterology and …
2020
49 次引用
The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systematic Review of Randomized Controlled Clinical Trials.
Systematic Review
Nutrients
2020
48 次引用
Nutrients
2020
30 次引用
Digestive and liver …
2020
14 次引用
Medicine
2020
4 次引用
International journal of …
2019
137 次引用
Critical reviews in …
2019
48 次引用
Journal of medicinal …
2019
17 次引用
Current opinion in …
2019
5 次引用
Gastroenterology clinics of …
2018
67 次引用
Macromolecular bioscience
2018
13 次引用
Gastroenterology
2017
335 次引用
Medical principles and …
2017
45 次引用
JPEN. Journal of …
2017
24 次引用
Comparison of remicade to curcumin for the treatment of Crohn's disease: A systematic review.
Systematic Review
Complementary therapies in …
2017
23 次引用
The Medical clinics …
2017
9 次引用
Ugeskrift for laeger
2017
Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohn's Disease and Ulcerative Colitis.
Review
Current pharmaceutical design
2016
32 次引用
Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases.
Systematic Review
Journal of Crohn's …
2015
184 次引用
Annals of gastroenterology
2015
135 次引用
Molecules (Basel, Switzerland)
2014
122 次引用
Experimental cell research
2014
16 次引用
The AAPS journal
2013
1866 次引用
Alimentary pharmacology & …
2013
128 次引用
Tolerability of curcumin in pediatric inflammatory bowel disease: a forced-dose titration study.
Other
Journal of pediatric …
2013
103 次引用
Nature reviews. Gastroenterology …
2013
47 次引用
Food & function
2012
151 次引用
Journal of the …
2009
24 次引用
Molecular nutrition & …
2008
67 次引用
Revista de gastroenterologia …
2008
2 次引用
Digestive diseases and …
2005
461 次引用
Bioinformatics (Oxford, England)
2004
149 次引用
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
常用剂量
- general:
- 500-1,500 mg/day with piperine (black pepper extract) for absorption
- ibssupport:
- 500-1,000 mg/day
- ucmaintenance:
- 2,000 mg/day (1 g twice daily) as adjunct to mesalamine
上限： Well-tolerated up to 8 g/day in clinical trials (most studies use 1-2 g/day)
研究中使用的剂量
| 剂量 | 持续时间 | 效果 | N |
|---|---|---|---|
| None | -- | Positive | 2260 |
| Varying dosages | -- | Positive | -- |
| Peppermint oil, STW-5, psyllium, others | -- | Positive | -- |
| Curcumin nanoformulations | -- | Positive | -- |
| Various phytochemicals | -- | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
最佳服用时间： With meals containing fat and black pepper for enhanced absorption
Safety & Side Effects
已报告的副作用
- ⚠ GI discomfort (nausea, diarrhea, abdominal pain) at high doses
- ⚠ Yellow staining of skin/teeth with topical/oral contact
- ⚠ Increased gallbladder contractions (avoid with gallstones or bile duct obstruction)
- ⚠ Iron chelation (may reduce iron absorption at very high doses)
已知相互作用
- ● Anticoagulants (curcumin has antiplatelet properties; may increase bleeding risk)
- ● Chemotherapy agents (curcumin may alter drug metabolism via CYP enzyme inhibition)
- ● Sulfasalazine (additive anti-inflammatory effect — may be beneficial in IBD)
- ● Iron supplements (curcumin may chelate iron; space dosing)
- ● Piperine/black pepper (enhances curcumin bioavailability by 2,000% — commonly co-administered)
可耐受最高摄入量： Well-tolerated up to 8 g/day in clinical trials (most studies use 1-2 g/day)
在开始服用任何补充剂之前，请务必咨询您的医疗保健提供者。
Frequently Asked Questions
Does Curcumin help with 克罗恩病?
Based on 3 studies with 200 participants, there is limited but promising evidence that Curcumin may support 克罗恩病 management. Our evidence grade is C (Some Evidence).
How much Curcumin should I take for 克罗恩病?
Studies have used various dosages. A commonly studied range is 500-1,500 mg/day with piperine (black pepper extract) for absorption. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Curcumin?
Reported side effects may include GI discomfort (nausea, diarrhea, abdominal pain) at high doses, Yellow staining of skin/teeth with topical/oral contact, Increased gallbladder contractions (avoid with gallstones or bile duct obstruction), Iron chelation (may reduce iron absorption at very high doses). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Curcumin and 克罗恩病?
We rate the evidence as Grade C (Some Evidence). This rating is based on 3 peer-reviewed studies with 200 total participants. The overall direction of effect is mixed.
Related Evidence
Curcumin 用于其他健康状况
References
- [1] Mohammad Shehab et al.. Inflamm Bowel Dis. 2026. Comparative Efficacy of Medical Therapies in Reducing the Risk of Postoperative Recurrence in Crohn's Disease: A Systematic Review and Network … doi:10.1093/ibd/izaf186 PubMed
- [2] Saeid Mohseni et al.. Front Nutr. 2025. Curcumin for the clinical treatment of inflammatory bowel diseases: a systematic review and meta-analysis of placebo-controlled randomized clinical trials. doi:10.3389/fnut.2025.1494351 PubMed
- [3] Sandra Utz et al.. Z Gastroenterol. 2024. [Phytotherapeutic recommendations in medical guidelines for the treatment of gastroenterological diseases - a systematic review]. doi:10.1055/a-2279-5045 PubMed
- [4] Zi-Wen Meng et al.. World J Gastroenterol. 2024. Use of curcumin and its nanopreparations in the treatment of inflammatory bowel disease. doi:10.3748/wjg.v30.i3.280 PubMed
- [5] Lucas Fornari Laurindo et al.. Metabolites. 2023. Phytochemicals and Regulation of NF-kB in Inflammatory Bowel Diseases: An Overview of In Vitro and In Vivo Effects. doi:10.3390/metabo13010096 PubMed
- [6] Liuting Zeng et al.. Front Immunol. 2022. Curcumin and Curcuma longa Extract in the Treatment of 10 Types of Autoimmune Diseases: A Systematic Review and Meta-Analysis of … doi:10.3389/fimmu.2022.896476 PubMed
- [7] Hui-Fang Chiu et al.. Molecules. 2021. Gastroprotective Effects of Polyphenols against Various Gastro-Intestinal Disorders: A Mini-Review with Special Focus on Clinical Evidence. doi:10.3390/molecules26072090 PubMed
- [8] Ricardo de Alvares Goulart et al.. J Med Food. 2021. Effects of the Use of Curcumin on Ulcerative Colitis and Crohn's Disease: A Systematic Review. doi:10.1089/jmf.2020.0129 PubMed
- [9] Anthony Buisson et al.. United European Gastroenterol J. 2021. Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease. doi:10.1002/ueg2.12068 PubMed
- [10] Justyna Kikut et al.. Eur J Nutr. 2021. Diet supporting therapy for inflammatory bowel diseases. doi:10.1007/s00394-021-02489-0 PubMed
- [11] Masoumeh Atefi et al.. Adv Exp Med Biol. 2021. A Systematic Review of the Clinical Use of Curcumin for the Management of Gastrointestinal Diseases. doi:10.1007/978-3-030-56153-6_18 PubMed
- [12] Ken Sugimoto et al.. J Crohns Colitis. 2020. Highly Bioavailable Curcumin Derivative Ameliorates Crohn's Disease Symptoms: A Randomized, Double-Blind, Multicenter Study. doi:10.1093/ecco-jcc/jjaa097 PubMed
- [13] Gilles Bommelaer et al.. Clin Gastroenterol Hepatol. 2020. Oral Curcumin No More Effective Than Placebo in Preventing Recurrence of Crohn's Disease After Surgery in a Randomized Controlled Trial. doi:10.1016/j.cgh.2019.08.041 PubMed
- [14] Mariana Roque Coelho et al.. Nutrients. 2020. The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systematic Review of Randomized Controlled Clinical Trials. doi:10.3390/nu12082296 PubMed
- [15] Bartosz Malinowski et al.. Nutrients. 2020. The Rundown of Dietary Supplements and Their Effects on Inflammatory Bowel Disease-A Review. doi:10.3390/nu12051423 PubMed
- [16] Mathilde Boube et al.. Dig Liver Dis. 2020. Variation of faecal calprotectin level within the first three months after bowel resection is predictive of endoscopic postoperative recurrence in … doi:10.1016/j.dld.2020.03.020 PubMed
- [17] Zhenhuan Yang et al.. Medicine (Baltimore). 2020. The effectiveness and safety of curcumin as a complementary therapy in inflammatory bowel disease: A protocol of systematic review and … doi:10.1097/MD.0000000000022916 PubMed
- [18] Kathryn Burge et al.. Int J Mol Sci. 2019. Curcumin and Intestinal Inflammatory Diseases: Molecular Mechanisms of Protection. doi:10.3390/ijms20081912 PubMed
- [19] Fernando Cunha Neto et al.. Crit Rev Food Sci Nutr. 2019. Curcuminoids from Curcuma Longa: New adjuvants for the treatment of crohn's disease and ulcerative colitis? doi:10.1080/10408398.2018.1456403 PubMed
- [20] Tanyaporn Kaenkumchorn et al.. J Med Food. 2019. Dietary Management of Pediatric Inflammatory Bowel Disease. doi:10.1089/jmf.2019.0063 PubMed
- [21] Ron Shaoul et al.. Curr Opin Gastroenterol. 2019. Nutritional regulators of intestinal inflammation. doi:10.1097/MOG.0000000000000585 PubMed
- [22] Berkeley N Limketkai et al.. Gastroenterol Clin North Am. 2018. Nutritional Interventions in the Patient with Inflammatory Bowel Disease. doi:10.1016/j.gtc.2017.09.007 PubMed
- [23] Xusheng Xie et al.. Macromol Biosci. 2018. Silk Fibroin-Based Fibrous Anal Fistula Plug with Drug Delivery Function. doi:10.1002/mabi.201700384 PubMed
- [24] James D Lewis et al.. Gastroenterology. 2017. Diet as a Trigger or Therapy for Inflammatory Bowel Diseases. doi:10.1053/j.gastro.2016.10.019 PubMed
- [25] Islam Khan et al.. Med Princ Pract. 2017. Antioxidant Supplements and Gastrointestinal Diseases: A Critical Appraisal. doi:10.1159/000468988 PubMed
- [26] Moftah H Alhagamhmad et al.. JPEN J Parenter Enteral Nutr. 2017. Exploring and Enhancing the Anti-Inflammatory Properties of Polymeric Formula. doi:10.1177/0148607115625627 PubMed
- [27] Allaire Schneider et al.. Complement Ther Med. 2017. Comparison of remicade to curcumin for the treatment of Crohn's disease: A systematic review. doi:10.1016/j.ctim.2017.06.002 PubMed
- [28] Joshua Korzenik et al.. Med Clin North Am. 2017. Complementary and Integrative Gastroenterology. doi:10.1016/j.mcna.2017.04.009 PubMed
- [29] Christian Lodberg Hvas et al.. Ugeskr Laeger. 2017. [Nutrition and dietary supplement in chronic inflammatory bowel diesease]. PubMed
- [30] Alyssa Parian et al.. Curr Pharm Des. 2016. Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohn's Disease and Ulcerative Colitis. doi:10.2174/1381612822666151112145033 PubMed
- [31] J Langhorst et al.. J Crohns Colitis. 2015. Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases. doi:10.1093/ecco-jcc/jju007 PubMed
- [32] Aikaterini Triantafyllidi et al.. Ann Gastroenterol. 2015. Herbal and plant therapy in patients with inflammatory bowel disease. PubMed
- [33] Liza Vecchi Brumatti et al.. Molecules. 2014. Curcumin and inflammatory bowel disease: potential and limits of innovative treatments. doi:10.3390/molecules191221127 PubMed
- [34] Filippo Fontani et al.. Exp Cell Res. 2014. Redox regulation of MMP-3/TIMP-1 ratio in intestinal myofibroblasts: effect of N-acetylcysteine and curcumin. doi:10.1016/j.yexcr.2014.02.019 PubMed
- [35] Subash C Gupta et al.. AAPS J. 2013. Therapeutic roles of curcumin: lessons learned from clinical trials. doi:10.1208/s12248-012-9432-8 PubMed
- [36] S C Ng et al.. Aliment Pharmacol Ther. 2013. Systematic review: the efficacy of herbal therapy in inflammatory bowel disease. doi:10.1111/apt.12464 PubMed
- [37] David L Suskind et al.. J Pediatr Gastroenterol Nutr. 2013. Tolerability of curcumin in pediatric inflammatory bowel disease: a forced-dose titration study. doi:10.1097/MPG.0b013e318276977d PubMed
- [38] Kris Nys et al.. Nat Rev Gastroenterol Hepatol. 2013. Autophagy: a new target or an old strategy for the treatment of Crohn's disease? doi:10.1038/nrgastro.2013.66 PubMed
- [39] Manjeshwar Shrinath Baliga et al.. Food Funct. 2012. Curcumin, an active component of turmeric in the prevention and treatment of ulcerative colitis: preclinical and clinical observations. doi:10.1039/c2fo30097d PubMed
- [40] Alfred E Slonim et al.. J Am Coll Nutr. 2009. Effect of exclusion diet with nutraceutical therapy in juvenile Crohn's disease. doi:10.1080/07315724.2009.10719782 PubMed
- [41] William P Steward et al.. Mol Nutr Food Res. 2008. Curcumin in cancer management: recent results of analogue design and clinical studies and desirable future research. doi:10.1002/mnfr.200700148 PubMed
- [42] F J Bosques-Padilla et al.. Rev Gastroenterol Mex. 2008. [Current concepts about the treatment of inflammatory bowel disease, biological therapy]. PubMed
- [43] Peter R Holt et al.. Dig Dis Sci. 2005. Curcumin therapy in inflammatory bowel disease: a pilot study. doi:10.1007/s10620-005-3032-8 PubMed
- [44] Padmini Srinivasan et al.. Bioinformatics. 2004. Mining MEDLINE for implicit links between dietary substances and diseases. doi:10.1093/bioinformatics/bth914 PubMed
FDA 免责声明: 这些声明未经美国食品药品监督管理局（FDA）评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析，不构成医疗建议。在开始任何补充剂方案之前，请务必咨询您的医疗保健提供者。